Luminer, a labeling solutions provider specializing in extended content labels for pharmaceutical and OTC packaging, has completed an expansion of its primary manufacturing facility in Lakewood, NJ, adding 20,000 sq.- ft. of multi-purpose space.
 
The expansion brings the plant’s total space to 50,000 sq.-ft. and allows Luminer to accommodate its growing extended content label (ECL) business, creating floor space for a new state-of-the-art ECL production line. The investment will more than double Luminer’s ECL manufacturing capacity. The equipment’s modernized onserting and movable print and die stations will expand Luminer’s ECL production flexibility, an important factor for complicated, and customized arrangements used in clinical trials and other pharmaceutical product settings. 
 
Also, the expansion has allowed Luminer to segregate its quality inspection processes into a 7,000-square-foot climate-controlled independently managed production cell. Added to this QC inspection department are two new servo controlled rewind/inspection units equipped with 100% inspection capabilities.
 
“The expansion exemplifies Luminer’s most significant growth spurt in recent years, particularly in extended content labels for the clinical trial and pharmaceutical sectors – a niche where our versatility increasingly serves as a key differentiator,” said Tom Spina, president and chief executive officer of Luminer. “The additional space gives us ample room for new equipment, broadened capabilities and, of course, future growth as we make continued headway into various markets.”